2th March
08:00 Secretariat - Credentiation opening
RENAL CELL CANCER
Chairman: JORGE OLIVEIRA – PEDRO OLIVEIRA – STEPHEN RIGGS
09:00 – 09:15 HISTOLOGICAL SUBTYPES AND TREATMENT FERRAN ALGABA
09:15 - 09:30 THE PLACE OF TKI : STILL 1ST LINE IN METASTATIC RENAL CELL CANCER?
SÉRGIO BARROSO
09:30 – 09:45 COMBINATION THERAPY IN METASTATIC RENAL CELL CARCINOMA LUIS COSTA
09:45 – 10:15 IMMUNOTHERAPY AND NEW TARGETED THERAPIES ELISABETH HEATH
10:15 – 10:45 CLINICAL CASES ANDRÉ MANSINHO
DISCUSSION PANEL
JOSÉ NUNES MARQUES – ANTÓNIO ARAÚJO
10:45 – 11:05 coffee-break
BLADDER CANCER
Chairman: RUI HENRIQUE– ESTEVÃO LIMA – PAULO COSTA
11:05 – 11:20 PATHOLOGY REPORT IN BLADDER CANCER TO HELP THE BEST TREATMENT CARLOS LOPES
11:20 – 11:40 HOW DO I TREAT HIGH-RISK SUPERFICIAL BLADDER CANCER MAURIZIO BRAUSI
11:40 – 11:55 SURGERY ALONE IN INVASIVE BLADDER CANCER? STEPHEN RIGGS
11:55 – 12:05 WHAT ABOUT NEOADJUVANT CHEMOTHERAPY IN INVASIVE BLADER CANCER? ELISABETH HEATH
12:05 – 12:15 WHAT ABOUT RADIO IN INVASIVE BLADDER CANCER ANTHONY ZIETMAN
12:15 – 12:30 IS ADJUVANT CHEMOTHERAPY IN INVASIVE BLADDER CANCER - STATE OF THE ART,OR NOT? DEREK RAGHAVAN
12:30 – 13:00 CLINICAL CASES DEREK RAGHAVAN
DISCUSSION PANEL
BELMIRO PARADA – ISABEL FERNANDES – JORGE OLIVEIRA
13:00 – 14:30 Lunch
PROSTATE CANCER
Chairman: CARLOS LOPES – FRANCISCO PINA – ELISABETH HEATH
14:30 – 14:45 PROSTATE BIOPSY: CONTEMPORARY CHALLENGES BEYOND DIAGNOSIS RUI HENRIQUE
14:45 – 15:00 EPIDEMIOLOGY AND SCREENING GABRIEL HAAS
15:00 – 15:15 STROMAGENIC CARCINOMA OF THE PROSTATE CANCER BRIAN MILES
15:15 – 15:30 FUSION BIOPSY – MRI AND COMPLICATIONS BASHAR OMABASHA
15:30 – 16:30 Q & A
EDSON PONTES – ARNALDO FIGUEIREDO – LUIS COSTA
16:10 – 16:30 Coffee-Break
RENAL CELL CANCER
Chairman:
NUNO VAU – MAURIZIO BRAUSI – ALEJO RODRIGUEZ-VIDA
16:30 – 16:55 NEW AVENUES IN IMMUNOTHERAPY ALEJO RODRIGUEZ-VIDA
16:55 – 17:30 CLINICAL CASES NUNO VAU
DISCUSSION PANEL
HELDER MANSINHO – ANDRE MANSINHO
17:30– 17:45 CONCLUSIONS
INVASIVE BLADDER CANCER
Chairman: DEREK RAGHAVAN – F.CALAIS DA SILVA – EDSON PONTES
09:00 – 09:30 ARE THERE NEW INDICATIONS IN IMMUNOTHERAPY? CORA STERNBERG
09:30 – 09:50 CLINICAL CASES MÁRIO FONTES E SOUSA
09:50 – 10:15 DISCUSSION PANEL
FERNANDO FERRITO – HÉLDER MANSINHO
10:15– 10:40 Coffee-Break
INVASIVE BLADDER CANCER
Chairman: ANTÓNIO QUINTELA – MIGUEL BARBOSA - FRANCISCO BOTELHO
10:40 – 10:55 EVOLUTION OF THE PARADIGM IN THE TREATMENT OF ADVANCED UROTHELIAL CARCINOMA ISABEL FERNANDES
10:55 – 11:20 CLINICAL EXPERIENCE WITH IMMUNOTHERAPY IN INELEGIBLE PATIENTS TO CISPLATIN AND AFTER CISPLATIN THERAPY
JOSE ANGEL ARRANZ
11:20 – 11:50 DISCUSSION PANEL
PEDRO MADEIRA– CARLOS RABAÇA
PENILE CANCER
Chairman:
FERRAN ALGABA – LA FUENTE CARVALHO – STEPHEN RIGGS
11: 50– 12:05 FROM L.A.S.T. TO WHO TO SENTINEL LYMPH NODE: HPV IN PENILE CANCER. PEDRO OLIVEIRA
12:05 – 12:20 LYMPHADENECTOMY: WHEN? STEPHEN RIGGS
12:20 – 12:35 BRACHYTHERAPY: WHY AND WHEN? ANTHONY ZIETMAN
12:35 – 13:00 CLINICAL CASES STEPHEN RIGGS
DISCUSSION PANEL
AUGUSTO PEPE CARDOSO – JOSÉ LA FUENTE CARVALHO
PROSTATE CANCER
Chairman: DEREK RAGHAVAN – LUIS CAMPOS PINHEIRO – ARNALDO FIGUEIREDO
14:30 – 14:45 HOW DO I TREAT mCRPC? ELISABETH HEATH
14:45 – 15:00 SURGERY VS RADIOTHERAPY IN HIGH-RISK DISEASE PROSTATE CANCER STEPHEN RIGGS
15:00 – 15:15 CHEMOTHERAPY IS THERE A PLACE IN THE FUTURE? DEREK RAGHAVAN
15:15 – 15:55 CLINICAL CASES ELISABETH HEATH
DISCUSSION PANEL
ESTEVÃO LIMA – ANTONIO ARAUJO – MAURIZIO BRAUSI
PROSTATE CANCER
Chairman: PEDRO GOMES MONTEIRO – SÉRGIO BARROSO
15:55 – 16:10 NEW HORMONAL INDICATION IN HORMONAL SENSITIVE PROSTATE CANCER PATIENTS PEDRO NUNES
16:10– 16:25 UPFRONT CHEMOTHERAPY IN HORMONAL PROSTATE CANCER PATIENTS? YES OR NO? CHIARA RODRIGUES
16:25 – 16:50 DISCUSSION
FRANCISCO BOTELHO – MIGUEL BARBOSA – FERNANDO FERRITO
PROSTATE CANCER
Chairman: PAULO COSTA – EDSON PONTES – ANTHONY ZIETMAN
16:50 – 17:05 WHEN TO WATCH AND WAIT? FRANCISCO PINA
17:05 – 17:20 CRYOTHERAPY: A VALID OPTION? EDSON PONTES
17:20 – 17:35 WHAT’S NEW IN ANDROGEN RECEPTOR FUNCTION AND NEW AGENTS? DEREK RAGHAVAN
17:35 – 17:50 RADIUM 223 & ADVANCES IN RADIOTHERAPY ANTHONY ZIETMAN
17H50 – 18:10 DISCUSSION PANEL
PEDRO NUNES – FERNANDO MANUEL CALAIS DA SILVA
MEETING ORGANIZERS
GPGU – Portuguese Genitourinary Group
Levine Cancer Institute / Carolinas Healthcare System
SCIENTIFIC BOARD
Fernando Calais da Silva – Chairman of the portuguese genitourinary group
Derek Raghavan – President of Levine Cancer Institute, Carolinas HealthCare System
University of Noth Carolina School of Medicine
Maurizio Brausi – Chairman of ESOU - EAU Section of Oncological Urology
INTERNATIONAL FACULTY
Alejo Rodriguez-Vida -
IMIM Hospital del Mar Medical Research Institute - Barcelona
Anthony Zietman
– Massachusetts General Hospital – Harvard Medical School
Bashar Omarbasha
– Upstate Medical University – Syracuse
Brian Miles
– Baylor School of Medicine and Methodist Hospital – Houston
Cora Sternberg -
San Camillo and Forlanini Hospitals - Roma
Derek Raghavan
– Levine Cancer Institute – Carolinas HealthCare System – UNC School of
Medicine - Charlotte
Edson Pontes
Karmanos Cancer center – Wayne State University School of Medicine – Detroit
Elisabeth Heath
– Karmanos Cancer Institute – Wayne State University School of Medicine
Detroit
Ferran Algaba
-Fundacio Puigvert – Barcelona
Gabriel Haas
– Loyola University – Maywood
Jose Angél Arranz
- HGU Gregorio Marañón - Madrid
Maurizio Brausi
–
Chairman ESOU - EAU Section of Oncological Urology
Pedro Oliveira
– Christie Hospital – Manchester
Stephen Riggs
– Levine Cancer Institute – UNC School of Medicine - Charlotte
PORTUGUESE FACULTY
Andre Mansinho
– C.H.L.N. HospitaL Santa Maria – Lisboa
António Araújo
- C.H.P. Hospital Santo António – Porto
António Quintela –
C.H.L.N. Hospital Santa Maria – Lisboa
Arnaldo Figueiredo -
C.H.U.C. – Coimbra
Augusto Pepe Cardoso
– Hospital Fernando da Fonseca - Amadora
Belmiro Parada
C.H.U.C. – Coimbra
Carlos Lopes
– ICBAS – Porto
Carlos Rabaça
– I.P.O. – Coimbra
Chiara Rodrigues
– C.H.L.C. Hospital dos Capuchos - Lisboa
Estevão Lima
– Hospital Universitário – Braga
Fernando Ferrito
– Hospital Fernando da Fonseca – Amadora
Fernando Manuel Calais da Silva
– C.H.L.C. Hospital São José – Lisboa
Francisco Botelho
– C.H.P. Hospital São João – Porto
Helder Mansinho
- Hospital Garcia de Orta – Almada
Isabel Fernandes -
C.H.L.N. Hospital Santa Maria – Lisboa
José La Fuente Carvalho -
C.H.P. Hospital Santo António - Porto
José Nunes Marques
– C.H.L.O. Hospital São Francisco Xavier – Lisboa
Jorge Oliveira
- I.P.O. – Porto
Luis Campos Pinheiro
– C.H.L.C. Hospital São José – Lisboa
Luis Costa -
C.H.L.N. Hospital Santa Maria – Lisboa
Mário Fontes e Sousa
- I.P.O. – Porto
Miguel Barbosa –
C.H.T.M.A.D. Hospital de Vila Real
Nuno Vau
– Fundação Champalimaud – Lisboa
Paulo Costa
– Hospital Universitário – Braga
Pedro Gomes Monteiro
– C.H.L.O. Hospital Egas Moniz – Lisboa
Pedro Madeira -
I.P.O. – Coimbra
Pedro Nunes –
C.H.U.C. -Coimbra
Rui Henrique –
I.P.O. – Porto
Sérgio Barroso –
Clinica S.António - Amadora
